Derivative Instruments	3 Months Ended
Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Note 5. Derivative Instruments As part of the Company’s foreign currency risk management program, the Company uses foreign currency forward contracts to mitigate the volatility related to fluctuations in the foreign exchange rates. These foreign currency forward contracts are not designated as hedging instruments. Derivative transactions such as foreign currency forward contracts are measured in terms of the notional amount; however, this amount is not recorded on the consolidated balance sheets and is not, when viewed in isolation, a meaningful measure of the risk profile of the derivative instruments. The notional amount is generally not exchanged but is used only as the underlying basis on which the value of foreign exchange payments under these contracts is determined. As of March 31, 2023 and December 31, 2022, the Company had 8,506 and 11,816 open foreign exchange contracts, respectively. As of March 31, 2023 and December 31, 2022, the Company had foreign currency forward contracts outstanding with a notional amount of $29.1 million and $54.7 million, respectively. The Company records all derivative instruments in the condensed consolidated balance sheets at their fair values. For the three months ended March 31, 2023 and for the year ended December 31, 2022, the Company recorded an asset of $0.1 million and a liability of $0.1 million, respectively, related to outstanding foreign exchange contracts. The Company recognized a loss of $1.3 million and a gain of $0.3 million during the three months ended March 31, 2023 and March 31, 2022, respectively. Gains and losses are included as a component of general and administrative expense within the condensed consolidated statements of operations and comprehensive loss.

Derivative Instruments

3 Months Ended

Mar. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Note 5. Derivative Instruments

As part of the Company’s foreign currency risk management program, the Company uses foreign currency forward contracts to mitigate the volatility related to fluctuations in the foreign exchange rates. These foreign currency forward contracts are not designated as hedging instruments. Derivative transactions such as foreign currency forward contracts are measured in terms of the notional amount; however, this amount is not recorded on the consolidated balance sheets and is not, when viewed in isolation, a meaningful measure of the risk profile of the derivative instruments. The notional

amount is generally not exchanged but is used only as the underlying basis on which the value of foreign exchange payments under these contracts is determined. As of March 31, 2023 and December 31, 2022, the Company had 8,506 and 11,816 open foreign exchange contracts, respectively. As of March 31, 2023 and December 31, 2022, the Company had foreign currency forward contracts outstanding with a notional amount of $29.1 million and $54.7 million, respectively.

The Company records all derivative instruments in the condensed consolidated balance sheets at their fair values. For the three months ended March 31, 2023 and for the year ended December 31, 2022, the Company recorded an asset of $0.1 million and a liability of $0.1 million, respectively, related to outstanding foreign exchange contracts. The Company recognized a loss of $1.3 million and a gain of $0.3 million during the three months ended March 31, 2023 and March 31, 2022, respectively. Gains and losses are included as a component of general and administrative expense within the condensed consolidated statements of operations and comprehensive loss.